[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK3429345T3 - Anvendelser af rekombinant gær-afledt serumalbumin - Google Patents

Anvendelser af rekombinant gær-afledt serumalbumin Download PDF

Info

Publication number
DK3429345T3
DK3429345T3 DK17786853T DK17786853T DK3429345T3 DK 3429345 T3 DK3429345 T3 DK 3429345T3 DK 17786853 T DK17786853 T DK 17786853T DK 17786853 T DK17786853 T DK 17786853T DK 3429345 T3 DK3429345 T3 DK 3429345T3
Authority
DK
Denmark
Prior art keywords
applications
recombinant yeast
derived serum
serum album
album
Prior art date
Application number
DK17786853T
Other languages
English (en)
Inventor
Eva Balslev Jørgensen
Original Assignee
Albumedix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albumedix Ltd filed Critical Albumedix Ltd
Application granted granted Critical
Publication of DK3429345T3 publication Critical patent/DK3429345T3/da

Links

Classifications

    • A01N1/0221
    • A01N1/0231
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04Preserving or maintaining viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0606Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0607Non-embryonic pluripotent stem cells, e.g. MASC
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0635B lymphocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0636T lymphocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • A01N1/0284
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK17786853T 2016-10-04 2017-10-04 Anvendelser af rekombinant gær-afledt serumalbumin DK3429345T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16192276 2016-10-04
PCT/EP2017/075257 WO2018065491A1 (en) 2016-10-04 2017-10-04 Uses of recombinant yeast-derived serum albumin

Publications (1)

Publication Number Publication Date
DK3429345T3 true DK3429345T3 (da) 2019-11-25

Family

ID=57047137

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17786853T DK3429345T3 (da) 2016-10-04 2017-10-04 Anvendelser af rekombinant gær-afledt serumalbumin

Country Status (8)

Country Link
US (1) US20190216079A1 (da)
EP (3) EP3791719A1 (da)
JP (2) JP6928084B2 (da)
KR (2) KR102662031B1 (da)
CA (1) CA3038422A1 (da)
DK (1) DK3429345T3 (da)
ES (1) ES2761854T3 (da)
WO (1) WO2018065491A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7437385B2 (ja) 2018-09-06 2024-02-22 バヴァリアン・ノルディック・アクティーゼルスカブ 保管が改善されたポックスウイルス組成物
KR20220031555A (ko) 2019-06-11 2022-03-11 옥소젠 코포레이션 조직의 습식 보존
WO2021111143A1 (en) 2019-12-04 2021-06-10 Albumedix Limited Methods and compositions produced thereby
EP4117722A1 (en) 2020-03-12 2023-01-18 Bavarian Nordic A/S Compositions improving poxvirus stability
CN113549653B (zh) * 2020-04-23 2024-03-22 上海赛比曼生物科技有限公司 用于慢病毒载体长期存贮的组合试剂
JP7280623B2 (ja) * 2020-12-28 2023-05-24 株式会社アビー 細胞凍結保存液、及び細胞凍結方法
JP7318983B2 (ja) * 2021-12-21 2023-08-01 株式会社アビー 細胞凍結保存液、及び細胞凍結方法
WO2024018452A1 (en) 2022-07-18 2024-01-25 Yeda Research And Development Co. Ltd. Albumin protein variants, production thereof and uses of same
CN117783501B (zh) * 2024-02-26 2024-05-10 四川大学华西第二医院 辛酸钠在注意缺陷与多动障碍中的应用及产品

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728553A (en) 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
FR2746109B1 (fr) * 1996-03-12 1998-04-17 Rhone Poulenc Rorer Sa Milieu pour la conservation de materiel biologique
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
DK1329460T3 (da) 2000-10-24 2006-07-31 Chemo Sero Therapeut Res Inst Fremgangsmåde til monomerisering af polymerer af humant serum albumin
JP4798833B2 (ja) 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 加熱処理工程を含むヒト血清アルブミンの製造方法
JP4798832B2 (ja) 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法
JP2004238392A (ja) * 2003-01-14 2004-08-26 Nipro Corp 安定化された蛋白質性製剤
GB0310347D0 (en) 2003-05-07 2003-06-11 Delta Biotechnology Ltd Assay
DK1710250T3 (da) 2004-01-20 2009-07-06 Chemo Sero Therapeut Res Inst Fremgangsmåde til fremstilling af humanserumalbumin ved varnebehandling i tilstedeværelse af divalt kation
SG2014012918A (en) 2009-02-11 2014-04-28 Novozymes Biopharma Dk As Albumin variants and conjugates
WO2010128142A1 (en) * 2009-05-07 2010-11-11 Novozymes Biopharma Dk A/S Method for purifying albumin
JP2013509170A (ja) 2009-10-30 2013-03-14 ノボザイムス バイオファーマ デーコー アクティーゼルスカブ アルブミン変異体
WO2011075686A2 (en) * 2009-12-18 2011-06-23 Ventria Bioscience Methods & compositions comprising heat shock proteins
US20130157356A1 (en) * 2010-01-25 2013-06-20 Ventria Bioscience Methods & compositions for improving protein production
EP2556087A1 (en) 2010-04-09 2013-02-13 Novozymes Biopharma DK A/S Albumin derivatives and variants
US10844349B2 (en) 2011-07-05 2020-11-24 Albumedix Ltd. Albumin formulation and use
EP2885969B1 (en) * 2013-12-19 2018-06-27 FertiPro N.V. Cryopreservation tools and methods

Also Published As

Publication number Publication date
KR20190052075A (ko) 2019-05-15
KR20230128591A (ko) 2023-09-05
ES2761854T3 (es) 2020-05-21
EP3603391A1 (en) 2020-02-05
CA3038422A1 (en) 2018-04-12
KR102573478B1 (ko) 2023-09-04
WO2018065491A1 (en) 2018-04-12
JP2021176336A (ja) 2021-11-11
EP3429345B1 (en) 2019-09-11
JP6928084B2 (ja) 2021-09-01
JP7249387B2 (ja) 2023-03-30
EP3791719A1 (en) 2021-03-17
EP3429345A1 (en) 2019-01-23
KR102662031B1 (ko) 2024-05-03
US20190216079A1 (en) 2019-07-18
JP2019533442A (ja) 2019-11-21

Similar Documents

Publication Publication Date Title
DK3429345T3 (da) Anvendelser af rekombinant gær-afledt serumalbumin
DK3497117T5 (da) Nye alkalisk stabile immunglobulin-bindende proteiner
DK3571225T3 (da) Forbedrede serumalbuminbindere
DK3303395T3 (da) Anti-cd40-antistoffer og anvendelser deraf
MA42380A (fr) Anticorps se liant à tau
DK3344654T3 (da) Anti-lag-3-antistoffer
DK3292141T3 (da) Fusionsproteiner
DK3313845T3 (da) Konjugater af cysteinmanipulerede antistoffer
DK3274370T3 (da) Anti-ceacam6-antistoffer og anvendelser deraf
DK3244891T3 (da) Forbindelser til forbedring af mrna-splejsning
DK3242892T3 (da) Modificerede april-bindende antistoffer
MA42377A (fr) Anticorps se liant à tau
DK3350218T5 (da) Polyomavirus-neutraliserende antistoffer
DK3261720T3 (da) Antistoffer til tau og anvendelser deraf
DK3233857T3 (da) Faste former af fusionerede heteroaromatiske pyrrolidinoner
DK3458100T3 (da) Selektiv reduktion af cystein-manipulerede antistoffer
DK3254092T3 (da) Bestemmelse af en vægs termiske modstand
DK3199179T3 (da) Formulering af rekombinant fusionsprotein
DK3250593T3 (da) Anti-transthyretin-antistoffer
DK3434760T3 (da) Fremgangsmåder til forøgelse af mannose-indholdet i rekombinante proteiner
DK3350334T3 (da) Udtryk af rekombinante proteiner i trichoplusia ni pupper
MA42692A (fr) Compositions biopharmaceutiques
DK3544416T3 (da) Applikation af væsker
DK3224356T3 (da) Metoder til rekombinant udtrykkelse af beta-glucosidase-gen
DK3484921T3 (da) Anti-IL-22R antistoffer